Unknown

Dataset Information

0

Severe reaction to radiotherapy for breast cancer as the presenting feature of ataxia telangiectasia.


ABSTRACT:

Background

Severe early and late radiation reaction to radiotherapy is extremely rare in breast cancer patients. Such a reaction prompted an investigation into a 44-year-old mother (patient A-T213).

Methods

A neurological examination was performed and blood lymphocytes and skin fibroblasts were assessed for radiosensitivity chromosomally and by colony-forming assay. The ATM gene was sequenced and ATM mutations modelled by site-directed mutagenesis. The ATM kinase activity was also assessed.

Results

Patient A-T213 was normally ambulant with no ataxia and minimal other neurological features. T lymphocytes and skin fibroblasts were unusually radiosensitive, although less sensitive than in classical ataxia telangiectasia (A-T). A lymphoblastoid cell line and skin fibroblasts expressed ATM protein with some retained kinase activity. One missense ATM mutation c.8672G>A (p.Gly2891Asp) and a c.1A>G substitution were identified. In the modelling system, the p.Gly2891Asp mutant protein was expressed and shown to have residual ATM kinase activity.

Conclusion

Patient A-T213 has a milder form of A-T with biallelic ATM mutations, which may have contributed to breast cancer development, and certainly caused the severe radiation reaction. Ataxia telangiectasia should be investigated as a potential cause of untoward severe early and late radiation reactions in breast cancer patients.

SUBMITTER: Byrd PJ 

PROVIDER: S-EPMC3261689 | BioStudies | 2012-01-01

SECONDARY ACCESSION(S): NM_000051.3

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6874351 | BioStudies
2018-01-01 | S-EPMC5905168 | BioStudies
2010-01-01 | S-EPMC3261617 | BioStudies
2007-01-01 | S-EPMC1894771 | BioStudies
1000-01-01 | S-EPMC3167608 | BioStudies
2014-01-01 | S-EPMC4109553 | BioStudies
2011-01-01 | S-EPMC3744187 | BioStudies
2010-01-01 | S-EPMC2914013 | BioStudies
1000-01-01 | S-EPMC3286905 | BioStudies
2020-01-01 | S-EPMC7053315 | BioStudies